Kailera Therapeutics, Inc. (KLRA) is a Healthcare stock trading at $17.90 (as of 2026-07-20), with a market capitalization of $2.32B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Valuation — source: SEC EDGAR (first-party)
Price
$17.90
Market Cap
$2.32B
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)
$0.00
Financial Health — source: SEC EDGAR
Altman Z-Score
0.71 (distress)
Valuation vs Sector & Industry
Sector P/E (Healthcare)
21.1
Industry P/E (Pharmaceutical Products)
16.8
Company
Sector
Healthcare
Industry
Pharmaceutical Products
Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)